Wed, August 19, 2020
Tue, August 18, 2020
Mon, August 17, 2020
Fri, August 14, 2020

Matthew Harrison Downgraded (UBX) to Hold and Held Target at $50 on, Aug 18th, 2020

Matthew Harrison of Morgan Stanley, Downgraded "Unity Biotechnology, Inc." (UBX) to Hold and Held Target at $50 on, Aug 18th, 2020.

Matthew has made no other calls on UBX in the last 4 months.



There is 1 other peer that has a rating on UBX. Out of the 1 peers that are also analyzing UBX, all agrees with Matthew's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Elemer Piros of "Roth Capital" Downgraded from Strong Buy to Hold and Decreased Target to $40 on, Monday, August 17th, 2020